Skip to content
Search

Latest Stories

PSNC reminds contractors it'll be mandatory from July to send all script returns via MYS portal

The Pharmaceutical Services Negotiating Committee (PSNC) has informed that all prescription returns/referred back items and disallowed items will be received through the Manage Your Services (MYS) portal and submitted for payment using the same route from July 2022 (for the dispensing month of June 2022).


At present, using the MYS portal to receive referred back and disallowed items is optional with nearly half of all contractors signed up to receive these digitally. The remaining contractors currently receive their referred back and disallowed items in the post from the NHSBSA.

From July 2022, MYS will be the only route available to view and submit required information for all referred back and disallowed items. For those still using the paper-based route, the final paper referred back and disallowed items that will be sent through the post will relate to prescriptions dispensed in May 2022.

NHSBSA will process any paper referred back items that were sent out before the switchover. Contractors with paper referred back items from previous months should aim to complete the required information and return these to the NHSBSA together with their monthly prescription bundle as soon as possible to avoid any delays to payment. These returns will be processed in line with the guidance for the original submission method.

Using MYS for receiving digital referred back and disallowed items means contractors:

  • receive these items sooner;
  • can provide information required to processes referred back items faster;
  • can submit a challenge for any disallowed items electronically;
  • can track the progress of any referred back items throughout until the point they are processed; and
  • do not risk losing these items in transit.

Pharmacy contractors wishing to sign up to receive digital referred backs and disallowed items earlier than the July 2022 switchover should contact the MYS team by emailing nhsbsa.mys@nhs.net or via telephone 0300 330 1368 to enable access to these features on the MYS portal.

Once these features are enabled on MYS, paper referred back and disallowed items will no longer be posted to the pharmacy.

More For You

David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Keep ReadingShow less
NHS expands pharmacogenomics trial to enhance personalised medicine
The NHS is poised to take a bold step towards personalised medicine (gettyimages)

Personalised medicine: NHS expands pharmacogenomics trial across England

With this study, the NHS aims to address barriers to the national implementation of pharmacogenomics, making personalised medicine to become standard practice

A national pharmacogenomics research study is making significant progress towards adopting personalised medicine within the NHS.

Keep ReadingShow less
Integrating clinical pharmacists into general practice significantly reduced medicine costs, opioid prescriptions, and anxiolytic use
The growing presence of clinical pharmacists in GP practices is driving improvements in in quality of prescribing and patient safety (gettyimages)

Clinical pharmacists in GP practices improve prescribing quality, patient safety

Integrating clinical pharmacists into general practice significantly reduced medicine costs, opioid prescriptions, and anxiolytic use

The growing presence of clinical pharmacists in GP practices is driving improvements in in quality of prescribing and patient safety in primary care settings, a new study has revealed.

Keep ReadingShow less